KR100737736B1 - Novel Bacillus sp. WRD-2 isolated from soil and fibrinolytic agent composition comprising extracellular protease produced by the WRD-2 isolated from soil as an effective component - Google Patents

Novel Bacillus sp. WRD-2 isolated from soil and fibrinolytic agent composition comprising extracellular protease produced by the WRD-2 isolated from soil as an effective component Download PDF

Info

Publication number
KR100737736B1
KR100737736B1 KR1020010011804A KR20010011804A KR100737736B1 KR 100737736 B1 KR100737736 B1 KR 100737736B1 KR 1020010011804 A KR1020010011804 A KR 1020010011804A KR 20010011804 A KR20010011804 A KR 20010011804A KR 100737736 B1 KR100737736 B1 KR 100737736B1
Authority
KR
South Korea
Prior art keywords
wrd
soil
bacillus
isolated
enzyme activity
Prior art date
Application number
KR1020010011804A
Other languages
Korean (ko)
Other versions
KR20020071646A (en
Inventor
옥민
서원석
김현정
전방실
조영수
임수진
김민석
박진철
Original Assignee
(주)네오바이오텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27696706&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100737736(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by (주)네오바이오텍 filed Critical (주)네오바이오텍
Priority to KR1020010011804A priority Critical patent/KR100737736B1/en
Publication of KR20020071646A publication Critical patent/KR20020071646A/en
Application granted granted Critical
Publication of KR100737736B1 publication Critical patent/KR100737736B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

본 발명은 토양에서 분리한 신규한 바실러스 속 WRD-2(Bacillus sp. WRD-2, 기탁번호 KCTC 0869BP) 및 이 균주가 생산하는 세포외 단백질분해효소를 유효성분으로 하는 혈전용해제 조성물에 관한 것으로서, 토양을 시료로 채취하여 단백질분해효소의 분해환의 크기가 2cm 이상인 30개의 균주를 선별한 후 이 중 효소 활성이 가장 우수한 균주인 바실러스 속 WRD-2를 분리하였으며, 상기 본 발명 균주의 배양 시간별 균체 생육 및 효소 활성은 배양 6시간부터 급격히 증가해서 12∼15시간 가장 우수하고, 탄소원에 따른 균체 생육은 갈락토스를 첨가한 배지에서 가장 우수하고 효소 활성은 말토스를 3% 첨가한 배지에서 가장 우수하며, 질소원에 따른 균체 생육 및 효소 활성은 효모추출물을 첨가한 배지에서 가장 우수한데 특히 효소 활성은 효모추출물을 4% 첨가시 상대적으로 가장 우수하여 본 발명의 바실러스 속 WRD-2 및 이 균주가 생산하는 세포외 단백질분해효소를 유효성분으로 하는 혈전용해제 조성물은 뛰어난 혈전용해능이 있다.
The present invention relates to a novel Bacillus sp. WRD-2 ( Bacillus sp. WRD-2, Accession No. KCTC 0869BP) isolated from soil, and a thrombolytic composition comprising an extracellular protease produced by the strain as an active ingredient. Soil samples were collected from the soil, and 30 strains of at least 2 cm in size of proteolytic enzymes were selected. Among them, WRD-2 was isolated from Bacillus, the strain having the highest enzyme activity. And the enzyme activity is rapidly increased from 6 hours of culture, the best 12 to 15 hours, cell growth according to the carbon source is the best in the medium with galactose and the enzyme activity is the best in the medium with 3% maltose, Cell growth and enzyme activity according to nitrogen source were the best in the medium containing yeast extract. Especially, enzyme activity was relatively high when 4% of yeast extract was added. Best to thrombolytic agent composition as the extracellular proteinase which the Bacillus WRD-2, and the strain of the present invention as an active ingredient in the production ability is excellent thrombolysis.

바실러스 속 WRD-2, 단백질분해효소, 효소 활성, 혈전용해제 조성물, 혈전용해능.Bacillus genus WRD-2, protease, enzyme activity, thrombolytic composition, thrombolytic ability.

Description

토양에서 분리한 신규한 바실러스 속 WRD-2 및 이 균주가 생산하는 세포외 단백질분해효소를 유효성분으로 하는 혈전용해제 조성물{Novel Bacillus sp. WRD-2 isolated from soil and fibrinolytic agent composition comprising extracellular protease produced by the WRD-2 isolated from soil as an effective component} Thrombolytic composition using novel Bacillus genus QR-2 isolated from soil and extracellular protease produced by this strain as an active ingredient {Novel Bacillus sp. WRD-2 isolated from soil and fibrinolytic agent composition comprising extracellular protease produced by the WRD-2 isolated from soil as an effective component}             

도 1은 WRD-2 유래 혈전분해효소의 활성을 나타내는 분해환의 사진도,1 is a photograph of a degradation ring showing the activity of WRD-2 derived thrombolytic enzymes,

도 2는 WRD-2의 배양시간별 균체 생육(cell growth) 및 단백질분해효소의 활성을 나타낸 그래프,2 is a graph showing cell growth and protease activity of WRD-2 according to the incubation time;

도 3은 초기 pH 변화에 따른 WRD-2의 균체 생육 및 단백질분해효소의 활성을 나타낸 그래프,3 is a graph showing the cell growth and protease activity of WRD-2 according to the initial pH change,

도 4는 탄소원에 따른 WRD-2의 균체 생육 및 단백질분해효소의 활성을 나타낸 그래프,4 is a graph showing the cell growth and protease activity of WRD-2 according to the carbon source,

도 5는 질소원에 따른 WRD-2의 균체 생육 및 단백질분해효소의 활성을 나타낸 그래프,5 is a graph showing the cell growth and protease activity of WRD-2 according to the nitrogen source,

도 6은 WRD-2 유래 단백질분해효소의 pH에 따른 효소 활성을 나타낸 그래프,6 is a graph showing the enzyme activity according to the pH of WRD-2 derived protease,

도 7은 WRD-2 유래 단백질분해효소의 온도에 따른 효소 활성을 나타낸 그래 프,7 is a graph showing the enzyme activity according to the temperature of WRD-2 derived protease,

도 8은 WRD-2의 혈전용해능을 측정하기 위한 시간에 따른 분해환의 크기를 나타낸 그래프이다.
Figure 8 is a graph showing the size of the degradation ring with time for measuring the thrombolytic ability of WRD-2.

본 발명은 토양에서 분리한 신규한 바실러스 속 WRD-2(Bacillus sp. WRD-2) 및 이 균주가 생산하는 세포외 단백질분해효소(extracellular protease)를 유효성분으로 하는 혈전용해제 조성물에 관한 것으로서, 더욱 상세하게는 토양을 시료로 채취하여 1차적으로 30종의 균주를 선별하고 단백질분해효소의 활성을 측정하기 위한 최적의 배지에서 배양한 후 효소 활성을 조사하여 분리한 바실러스 속 WRD-2 및 이 균주가 생산하는 세포외 단백질분해효소를 유효성분으로 하는 혈전용해제 조성물에 관한 것이다.The present invention relates to a novel Bacillus sp. WRD-2 ( Bacillus sp. WRD-2) isolated from soil, and to a thrombolytic composition comprising an extracellular protease produced by the strain as an active ingredient. Specifically, WRD-2 and the strains of Bacillus sp. Isolated from the soil sample by first selecting 30 strains, culturing in an optimal medium for measuring the activity of protease, and then examining the enzyme activity. It relates to a thrombolytic composition comprising an extracellular protease which is produced as an active ingredient.

현대산업사회가 발달함에 따라 각종 효소의 이용도가 급격히 증가하고 있는 가운데 단백질분해효소는 단백질화학, 식품, 의약, 환경 등의 각종 제조산업 분야에서 그 요구가 증가되는 추세이며, 현재 총 효소산업 시장의 60% 정도를 점유하고 있는데, 특히 세린(-알칼라인) 단백질분해효소는 피혁, 세제공업 등의 분야에서 매우 중요한 효소단백질로 알려져 있다(Ward. O. P., 1985, Proteolytic Enzymes, in Comprehensive Biotechnology 1st ed. by M. Y. Murray, Pergamon press, 789 - 792).With the development of the modern industrial society, the use of various enzymes is rapidly increasing, and the proteolytic enzymes are increasing in various fields of manufacturing industry such as protein chemistry, food, medicine and environment. About 60% of the total amount of serine (-alkaline) protease is known to be a very important enzyme protein in the fields of leather and tax industry (Ward. OP, 1985, Proteolytic Enzymes, in Comprehensive Biotechnology 1st ed. by MY Murray, Pergamon press, 789-792).

바실러스 속은 이미 다양한 연구가 수행중인 미생물 중의 하나로서 알칼리조건, 중성조건 등에 따라 증식하는 종(species)이 각각 다르며 이들이 생산하는 단백질분해효소(Horikoshi, K., 1971, Production of alkaline enzymes by alkalophilic microorganism. part 1. alkaline protease produced by Bacillus No.221. Agr. Biol. Chem. 35 : 1407 - 1414; Manachini, P. L. 등, 1988, Themostable alkaline protease produced by Bacillus thermoruber a new species of Bacillus. Appl. Microbiol. Biotechnol. 28 : 409 - 413; Tsuru. D., H. 등, 1966, Studies on bacterial protease. Part 16. purification crystallization and some enzymic properites of alkaline protease of Bacillus subtilis var. amylosacchariticus. Agr. Biol. Chem. 30 : 1261 - 1268)는 산업적으로 다양하게 이용되고 있는데, 특히 바실러스 서브틸리스(Bacillus subtilis) 유래의 Subtilisin Calsberg(Guntelber, A. V., M. Ottesen., 1952, Preparation of crystals containing the plakalbumin forming enzyme from Bacillus subtilis. Nature(London) 170 : 802), Subtilisin BPN(Smith, E. L. 등, Markland. 1968. Subtilism Calsberg. V. The complete sequence: comparison with subtilisin BPN: evolutionary relationship. J. Biol. Chem. 243 : 2184 - 2191), Subtilisin Novo(Ottesen, M., A. Spector., 1960, A comparison of two proteinases from Bacillus subtilis. C.R. Trav. Lab. Calsberg. 32 : 63 - 74) 등이 주로 사용되고 있다. The genus Bacillus is one of the microorganisms that have already been researched and has different species to grow according to alkaline and neutral conditions, and they produce different enzymes (Horikoshi, K., 1971, Production of alkaline enzymes by alkalophilic microorganism. part 1. alkaline protease produced by Bacillus No.221 Agr Biol Chem 35:....... 1407 - 1414; Manachini, PL , etc., 1988, Themostable alkaline protease produced by Bacillus thermoruber a new species of Bacillus Appl Microbiol Biotechnol. 28 : 409-413; Tsuru.D., H. et al., 1966, Studies on bacterial protease.Part 16.purification crystallization and some enzymic properites of alkaline protease of Bacillus subtilis var. Amylosacchariticus.Agr . Biol. Chem . 30 : 1261 1268) is used in a variety of industries, in particular Subtilisin Calsberg from Bacillus subtilis (Guntelber, AV, M. Ottesen., 1952, Preparation of crystals containing th e plakalbumin forming enzyme from Bacillus subtilis.Nature (London) 170: 802), Subtilisin BPN (Smith, EL et al., Markland. 1968. Subtilism Calsberg. V. The complete sequence: comparison with subtilisin BPN: evolutionary relationship. J. Biol. Chem. 243 : 2184-2191), Subtilisin Novo (Ottesen, M., A. Spector., 1960, A comparison of two proteinases from Bacillus subtilis . CR Trav. Lab. Calsberg. 32 : 63-74).

혈전용해효소(Fibrinolytic enzyme)는 피브린(fibrin)을 용해시키는 일종의 단백질분해효소이다. 정상적인 조건에서 피브린의 생성과 분해는 생체내 트롬빈(thrombin) 및 플라스민(plasmin)에 의해 적절히 조절된다. 그러나 이들의 균형이 깨어져 혈전(blood clot)이 혈관 벽에 부착·누적되면 혈관을 좁게 만들거나, 더 나아가 혈류를 따라 뇌혈관과 같은 미세혈관에 침입하여 이를 폐쇄함으로써 각종 순환계 질환을 야기한다. 우리 신체는 혈관을 통하여 각 조직에 영양물질과 산소를 공급함으로써 신진대사를 유지해 나가므로 건강한 생활을 영위하기 위해서는 순환계의 원활한 흐름이 매우 중요하다.Fibrinolytic enzymes are a type of proteolytic enzyme that dissolves fibrin. Under normal conditions, fibrin production and degradation are properly regulated by thrombin and plasmin in vivo. However, when their balance is broken and blood clots adhere to and accumulate on the walls of blood vessels, blood vessels are narrowed, or further, they invade and close microvascular vessels such as cerebrovascular vessels along the bloodstream, causing various circulatory diseases. Since our body maintains metabolism by supplying nutrients and oxygen to each tissue through blood vessels, smooth flow of the circulatory system is very important for healthy living.

현재, 우리 나라에서도 식생활의 서구화와 지방의 과다 섭취 등의 원인으로 혈전성 성인병이 날로 늘어가는 추세에 있다. 우리 나라의 경우 순환계 질환(고혈압성질환, 뇌혈관성질환, 허혈성심장질환)으로 인한 사망자수가 전체의 24.6%로 가장 높고, 다음으로 신생물(각종암, 백혈병 등)로 인한 사망자수가 21.7%, 각종사고사로 인한 사망자수가 14.5%로 보고되어 있다(인구분석과. 1997. 96년 사망원인 통계 결과. 통계청. 한국). 특히, 순환계 질환 중 뇌혈관 질환은 50대 이상의 연령층에서 제1의 사망원인으로 보고되어 있는 바 이러한 순환계 질환은 노인성질환이라 할 수 있다. 점차 노령화되어가고 있는 사회구조와 노인성치매 환자의 60%가 혈전때문이라는 사실을 감안할 때 이러한 순환계 질환으로 인한 사망률은 줄어들지 않을 전망이다. 따라서, 이러한 순환계 질환에 대한 대책은 간과할 수 없는 중요한 문제이므로 혈전용해제의 개발에 대한 중요성과 필요성이 크게 대두되고 있다.At present, thrombotic adult disease is increasing in Korea due to westernization of diet and excessive intake of fat. In Korea, the highest number of deaths due to circulatory diseases (hypertensive disease, cerebrovascular disease, ischemic heart disease) is 24.6%, followed by 21.7% of neoplasms (various cancers, leukemias, etc.). The death toll from accidents is reported at 14.5% (Population Analysis. 1997. Statistics of Causes of Death in 1996. National Statistical Office. Korea). In particular, the cerebrovascular disease of the circulatory disease is reported as the first cause of death in the 50s or older age bar This circulatory disease may be referred to as senile disease. Given the aging social structure and the fact that 60% of senile dementia patients are caused by blood clots, the mortality rate from these circulatory diseases is unlikely to decrease. Therefore, the countermeasures against such circulatory diseases are an important problem that cannot be overlooked, and thus the importance and necessity for the development of thrombolytics have emerged.

우리 나라에서도 최근에 전통 발효 식품으로부터 혈전용해효소를 생산하는 연구가 수행된 바 있다. 김 등은 청국장으로부터 유래한 Bacillus sp. strain CK 11-4로부터 혈전용해효소를 분리하였는데(Kim, W. K. 등, 1996, Purification and Characterization of a Fibrinolytic Enzyme Produced from Bacillus sp. Strain CK 11-4 Screened from Chungkook-jang, Appl. Environ. Microbiol., 62: 2482 - 2488), 이 효소는 열에 매우 안정적이며 혈전용해능이 강한 특징이 있다고 보고되어 있다. 또한, 김 등은 젓갈에서 분리한 Bacillus sp. KA 38을 이용한 새로운 혈전용해효소의 생산과 특성에 대하여 보고한 바 있다(Kim, H. K. 등, 1997, Purification and Charaterization of a Novel Fibrinolytic Enzyme from Bacillus sp. KA38 Originated from Fermented Fish. J. Ferment. Bioeng., 84 : 307 - 312). 그러나, 토양에서 분리한 혈전용해능이 우수한 균주에 대해서는 아직까지 국내에 보고된 바 없다.Recently, researches on producing thrombolytic enzymes from traditional fermented foods have been conducted in Korea. Kim et al., Bacillus sp . It was remove the fibrinolytic enzyme from strain CK 11-4 (Kim, WK, etc., 1996, Purification and Characterization of a Fibrinolytic Enzyme Produced from Bacillus sp. Strain CK 11-4 Screened from Chungkook-jang, Appl. Environ. Microbiol., 62 : 2482-2488), it is reported that this enzyme is very stable to heat and has strong thrombolytic properties. In addition, seaweed etc. were isolated from Bacillus sp . The production and characterization of new thrombolytic enzymes using KA 38 has been reported (Kim, HK et al., 1997, Purification and Charaterization of a Novel Fibrinolytic Enzyme from Bacillus sp . KA38 Originated from Fermented Fish.J. Ferment.Bioeng . , 84: 307-312). However, there have not been any reports on the superior thrombolytic strains isolated from the soil in Korea.

본 발명자들은 상기와 같은 점들을 감안하여 안출한 것으로 토양으로부터 단백질분해효소의 활성이 우수한 균주를 선별하고, 상기 효소의 활성을 더 높일 수 있는 배양조건을 결정하고, 이에 따른 혈전용해능을 측정함으로써 본 발명을 완성하였다.The inventors of the present invention have been made in view of the above points by selecting strains excellent in the activity of protease from the soil, by determining the culture conditions that can further increase the activity of the enzyme, by measuring the thrombolytic ability accordingly The present invention has been completed.

따라서, 본 발명의 목적은 토양에서 분리한 신규한 바실러스 속 WRD-2 및 이 균주가 생산하는 세포외 단백질분해효소를 유효성분으로 하는 혈전용해능이 우수한 혈전용해제 조성물을 제공함에 있다.
Accordingly, it is an object of the present invention to provide a novel thrombolytic composition having excellent thrombolytic activity using the novel Bacillus genus WRD-2 isolated from soil and extracellular protease produced by the strain.

본 발명의 상기 목적은 토양을 시료로 채취하여 단백질분해효소의 분해환의 크기가 2cm 이상인 30개의 균주를 선별한 후 이 중 효소 활성이 가장 우수한 균주를 최종적으로 선별하여 미생물학적으로 동정하고, 배양시간, pH, 탄소원, 질소원에 따른 균체 생육 및 효소 활성, pH 및 온도에 따른 조효소액의 효소활성 및 혈전분해능을 측정함으로써 달성하였다.
The object of the present invention is to collect the soil as a sample to select 30 strains of the size of the degradation ring of the proteolytic enzyme more than 2cm and then finally select the strains with the highest enzyme activity microbiologically identified, incubation time This was achieved by measuring cell growth and enzyme activity according to pH, carbon source and nitrogen source, and enzyme activity and thrombolytic activity of crude enzyme solution according to pH and temperature.

이하, 본 발명의 구체적인 방법을 실시예를 들어 상세히 설명하고자 하지만 본 발명의 권리범위는 이들 실시예에만 한정되는 것은 아니다.
Hereinafter, the specific method of the present invention will be described in detail with reference to Examples, but the scope of the present invention is not limited only to these Examples.

실시예 1: 사용 균주의 분리 및 동정Example 1 Isolation and Identification of Strains Used

효소 활성이 우수한 단백질분해효소를 생산하는 균주를 선별하기 위하여 경남 김해시 일대의 논토양 및 밭토양으로부터 시료를 채취하였다. 채취된 시료를 멸균수로 적당히 희석한 후 순차적으로 탈지우유아가 배지(skim milk agar medium: skim milk 5g/ℓ, bactotryptone 10g/ℓ, yeast extract 5g/ℓ, NaCl 5g/ℓ, bactoagar 15g/ℓ)에 도말 하고 30℃의 항온배양기에서 15시간 이상 배양하여 생성된 균주들 중 탈지우유가 세포외 단백질분해효소에 의하여 분해되어 형성된 분해환(clear zone 또는 halo)이 상대적으로 큰 균주를 1차적으로 선별한 후 그 중 분해환의 직경이 2cm 이상인 30개의 균주를 2차적으로 선별하였다. 2차 선별된 균주 중에서 효소 활성이 가장 우수한 균주를 WRD-2로 명명하였다. 도 1은 WRD-2 유 래 혈전분해효소의 활성을 나타내는 분해환의 사진도이다. 세포외 단백질분해효소 활성을 유지하기 위하여 탈지우유 배지에서 계대 배양하면서 사용하였다. Samples were collected from paddy and field soils of Gimhae-si, Gyeongnam, in order to select strains producing protease with excellent enzyme activity. After properly diluting the sample with sterile water, skim milk agar medium (skim milk agar medium: skim milk 5g / ℓ, bactotryptone 10g / ℓ, yeast extract 5g / ℓ, NaCl 5g / ℓ, bactoagar 15g / ℓ) Among the strains produced by incubation for 15 hours at 30 ° C. incubator at 30 ° C., strains with relatively large clear zones or halo formed by digestion of the skim milk by extracellular protease were selected first. After that, 30 strains of which the diameter of the degradation ring was 2 cm or more were selected secondarily. Among the second screened strains, the best strain was named WRD-2. 1 is a photograph of a degradation ring showing the activity of WRD-2 derived thrombolytic enzymes. In order to maintain extracellular protease activity, it was used while subcultured in skim milk medium.

분리된 균주 WRD-2는 그람염색(Gram Staining)에서 양성을 나타내었으며, 포자염색(Spore Staining)에서는 포자가 존재하였고 원형의 균체(colony) 형태를 가지고 있었다.The isolated strain WRD-2 was positive in Gram staining, spores were present in spore staining and had a circular colony.

WRD-2의 동정을 위하여 생명공학연구소 유전자센터에 의뢰하여 API 50CHB kit로 동정한 결과 바실러스 속으로 동정되었다. 본 발명의 균주를 Bacillus sp. WRD-2로 명명하고, 상기 기관에 2000년 10월 2일에 기탁번호 KCTC 0869BP로 기탁하였다. 본 발명의 미생물 균주의 생리학적 특성을 표 1에 나타내었다. For identification of WRD-2, it was identified as API 50CHB kit by the Biotechnology Research Center Gene Center and identified as Bacillus. Bacillus sp. It was named WRD-2 and deposited with the institution under accession number KCTC 0869BP on 2 October 2000. The physiological characteristics of the microbial strains of the present invention are shown in Table 1.

본 발명의 바실러스 속 WRD-2의 생리학적 특성Physiological Characteristics of WRD-2 of the Genus Bacillus GlycerolGlycerol ++ SalicineSalicine ++ ErythritolErythritol -- CellobioseCellobiose ++ D-ArabinoseD-Arabinose -- MaltoseMaltose ++ L-ArabinoseL-Arabinose ++ LactoseLactose ++ RiboseRibose ++ MelibioseMelibiose ++ D-XyloseD-Xylose ++ SaccharoseSaccharose ++ L-XyloseL-Xylose -- TrehaloseTrehalose -- AdonitolAdonitol -- InulineInuline -- β-Methyl-xylosideβ-Methyl-xyloside -- MelezitoseMelezitose -- GalactoseGalactose -- D-RaffinoseD-Raffinose ++ D-GlucoseD-Glucose ++ AmidonAmidon ++ D-FructoseD-Fructose ++ GlycogenGlycogen ++ D-MannoseD-Mannose ++ XylitolXylitol -- L-SorboseL-Sorbose -- β-Gentibioseβ-Gentibiose ++ RhamnoseRhamnose -- D-TuranoseD-Turanose -- DulcitolDulcitol -- D-LyxoseD-Lyxose -- InositolInositol ++ D-TagatoseD-Tagatose -- ManitolManitol ++ D-FucoseD-Fucose -- SorbitolSorbitol ++ L-FucoseL-Fucose -- α-Methyl-D-mannosideα-Methyl-D-mannoside -- D-ArabitolD-Arabitol -- α-Methyl-D-glucosideα-Methyl-D-glucoside ++ L-ArabitolL-Arabitol -- N-Acetyl glucosamineN-Acetyl glucosamine -- GluconateGluconate -- AmygdalineAmygdaline ++ 2-Keto gluconate2-Keto gluconate -- ArbutineArbutine ++ 5-Keto gluconate5-Keto gluconate -- EsculineEsculine ++

실시예 2: 배양시간에 따른 균체 생육 및 효소 활성Example 2: Cell growth and enzyme activity according to incubation time

이하 실시예에서 본 발명의 균주인 WRD-2의 배양조건을 검토하기 위하여 배지로는 LB(Luria-Bertani) 배지(Bactotryptone 10g/ℓ, yeast extract 5g/ℓ, NaCl 5g/ℓ)를 사용하였고, 균체 생육은 LB 배지를 이용하여 3시간 간격으로 분광광도계(HP 8452A)를 사용하여 660 nm에서 흡광도를 측정하였다. 한편, 단백질의 정량분석은 소혈청알부민(Bovine serum albumin)을 표준단백질로 사용하여 로우리법(Lowry, O. H. 등, 1951, Protein Measurement with the folinphenol reagent. J. Biol. Chem. 193 : 265 - 275)에 따라 측정하였다.In the following Examples, LB (Luria-Bertani) medium (Bactotryptone 10g / L, yeast extract 5g / L, NaCl 5g / L) was used as a medium to examine the culture conditions of the strain WRD-2 of the present invention. Cell growth was measured at 660 nm using a spectrophotometer (HP 8452A) at 3 hours intervals using LB medium. On the other hand, quantitative analysis of protein was performed by Lowry, OH et al., 1951, Protein Measurement with the folinphenol reagent.J. Biol. Che m. 193: 265-275 using Bovine serum albumin as a standard protein. Was measured according to

배양시간에 따른 균체 생육과 단백질분해효소의 활성을 측정하기 위하여 LB 배지 100 ㎖에 동일배지에서 배양한 WRD-2 전배양액을 3% 접종하고 180 rpm으로 30℃에서 배양하면서 2시간 간격으로 배양액을 취하여 균체 생육과 효소 활성을 측정하였다. 이때 효소 활성의 측정은 하기하라(Hagihara) 등의 방법으로 측정하였다(Hagihara, B., H. 등, 1958, Crystalline bacterial proteinase. 1. Preparation of crystalline proteinase of Bacillus subtilis. J. Biochem. 45 : 185 - 194). 즉, 50 mM 붕산나트륨-NaOH 버퍼(pH 10.4)에 1 mM CaCl2 및 0.6% 탈지우유 카세인을 혼합하여 기질용액으로 사용하였고, 반응은 0.5㎖의 기질용액과 0.1㎖의 효소액을 혼합한 후 37℃에서 10분간 실시하였다. 그후, 얼음조(ice bath)를 사용하여 반응액의 반응을 정지시키고 상기 반응액에 5% 트리클로로아세트산 0.5㎖를 첨가하여 실온에서 20분간 방치한 후 10,000×g으로 10분간 원심 분리하여 상등액을 280nm에서 흡광도를 측정하였다. 효소 활성의 1unit(U)은 흡광도를 분당 0.002 증가시키는데 필요한 효소의 양으로 정하였다.In order to measure cell growth and protease activity according to the incubation time, 3% of WRD-2 preculture was inoculated in 100 ml of LB medium and incubated at 30 ° C at 180 rpm for 2 hours. Cell growth and enzyme activity were measured. The enzyme activity was measured by the method of Hagihara et al. (Hagihara, B., H. et al., 1958, Crystalline bacterial proteinase. 1. Preparation of crystalline proteinase of Bacillus subtilis . J. Biochem . 45 : 185 -194). That is, 1 mM CaCl 2 and 0.6% skim milk casein were mixed in 50 mM sodium borate-NaOH buffer (pH 10.4) and used as a substrate solution.The reaction was performed after mixing 0.5 ml of substrate solution and 0.1 ml of enzyme solution. It carried out for 10 minutes at ° C. Thereafter, the reaction of the reaction solution was stopped using an ice bath, and 0.5 ml of 5% trichloroacetic acid was added to the reaction solution, which was allowed to stand at room temperature for 20 minutes, followed by centrifugation at 10,000 × g for 10 minutes. Absorbance was measured at 280 nm. One unit (U) of enzyme activity was determined by the amount of enzyme required to increase the absorbance 0.002 per minute.

본 발명의 균주인 WRD-2의 배양시간별 균체 생육과 단백질분해효소의 활성을 조사한 결과를 도 2에 나타내었다. 균체 생육은 배양 6시간부터 급격히 증가하기 시작하여 배양 15시간째 가장 높았고 그 후부터는 다시 감소하였다. 상기 결과는 본 발명자들이 이전에 분리한 바실러스 속 WRD-1의 배양시간에 따른 균체 생육 및 단백질분해효소의 활성과 유사하였다(OK M. 등, Characterization of Extracellular protease of Bacillus sp. WRD-1 Isolated from Soil. Kor. J. Appl Microbiol. Biotechnol. vol 28. No 6. 329-333(2000)). 상기 결과를 감안하여 이후 실험에서는 15시간 배양 후의 결과를 채택하였다.
The results of investigating cell growth and protease activity of each strain of WRD-2 according to the present invention are shown in FIG. 2. Cell growth began to increase rapidly from 6 hours of cultivation, the highest at 15 hours of cultivation, and then decreased again. The results were similar to the cell growth and protease activity according to the incubation time of the WRD-1 genus previously isolated from Bacillus (OK M. et al., Characterization of Extracellular protease of Bacillus sp.WRD-1 Isolated from Soil.Kor . J. Appl Microbiol.Biotechnol.vol 28. No 6. 329-333 (2000)). In view of the above results, the results after 15 hours of incubation were adopted in the experiment.

실시예 3: 초기 pH 변화에 따른 균체 생육 및 단백질분해효소의 활성Example 3: Cell Growth and Protease Activity According to Initial pH Change

배지의 초기 pH를 4∼10으로 조정한 후 WRD-2 전배양액을 각각 3%씩 접종하고 30℃에서 15시간 배양한 후 균체 생육 및 단백질분해효소의 활성을 측정하였다. 그 결과를 도 3에 나타내었다.After adjusting the initial pH of the medium to 4-10, 3% each of the WRD-2 preculture was inoculated and incubated at 30 ° C. for 15 hours, and then cell growth and protease activity were measured. The results are shown in FIG.

초기 pH를 5∼9로 조정한 경우 균체 생육은 전체적으로 양호하였지만 효소 활성은 pH 4부터 증가하기 시작하여 pH 6에서 최대이었으며, 초기 pH를 6∼8로 조정한 경우 균체 생육 및 단백질분해효소의 활성이 최대이었다.
When the initial pH was adjusted to 5-9, cell growth was generally good, but the enzyme activity started to increase from pH 4 to maximum at pH 6, and when the initial pH was adjusted to 6-8, cell growth and protease activity were observed. This was up.

실시예 4: 탄소원에 따른 균체 생육 및 단백질분해효소의 활성Example 4: Cell Growth and Protease Activity According to Carbon Sources

LB 배지에 글루코스, 말토스, 수크로스, 락토스, 갈락토스를 각각 3% 농도로 첨가하여 30℃에서 180rpm으로 진탕하면서 15시간 배양한 후 균체 생육 및 단백질분해효소의 활성을 측정하였다. 그 결과를 하기 표 2에 나타내었다. Glucose, maltose, sucrose, lactose and galactose were added to the LB medium at 3% concentrations, and cultured for 15 hours with shaking at 180 rpm at 30 ° C., and cell growth and protease activity were measured. The results are shown in Table 2 below.                     

본 발명의 바실러스 속 WRD-2의 탄소원에 따른 균체 생육 및 단백질분해효소의 활성Activity of Cell Growth and Protease Activity According to Carbon Source of WRD-2 of the Genus Bacillus 탄소원Carbon source 균체생육 (660nm에서의 흡광도)Cell growth (absorbance at 660 nm) 단백질분해효소 활성 (U/㎖)Protease Activity (U / mL) 글루코스Glucose 1.50481.5048 37.9237.92 수크로스Sucrose 1.43771.4377 33.5533.55 말토스Maltose 1.97541.9754 64.0264.02 갈락토스Galactose 2.47882.4788 45.3245.32 락토스Lactose 2.27412.2741 28.4128.41

사용된 탄소원에 따른 균체 생육은 갈락토스를 사용하였을 때 가장 양호하였으며, 효소 활성은 말토스를 사용하였을 때 64.02U/㎖로 가장 높았다. 단백질분해효소의 활성이 탄소원으로서 말토스를 사용하였을때 가장 높은 점을 감안하여 말토스의 농도를 0%, 1%, 2%, 3%, 4%로 하여 30℃에서 15시간 배양 후 단백질분해효소의 활성을 측정하였다. 그 결과 말토스의 농도가 3%일때 다른 농도에 비해 상대적으로 단백질분해효소의 활성이 가장 높았다. 그 결과를 도 4에 나타내었다.
Cell growth according to the carbon source used was the best when using galactose, the enzyme activity was the highest with 64.02U / ㎖ using maltose. Considering that the activity of protease was the highest when maltose was used as a carbon source, the concentration of maltose was 0%, 1%, 2%, 3%, and 4%, followed by proteolysis after 15 hours incubation at 30 ° C The activity of the enzyme was measured. As a result, when the concentration of maltose was 3%, the activity of protease was the highest compared to other concentrations. The results are shown in FIG.

실시예 5: 질소원에 따른 균체 생육 및 단백질분해효소의 활성Example 5: Cell Growth and Protease Activity According to Nitrogen Sources

LB 배지에서 질소원인 1% tryptone 대신에 동일한 농도의 펩톤, 효모추출물, 맥아추출물, NaNO3, (NH4)2SO4, NH4Cl, 카세인, 대두(soybean)로 대체하여 30℃에서 180rpm으로 진탕하면서 15시간 배양한 후 균체 생육과 효소 활성을 측정하였다. 그 결과를 표 3에 나타내었다. Instead of 1% tryptone as a nitrogen source in LB medium, the same concentration of peptone, yeast extract, malt extract, NaNO 3 , (NH 4 ) 2 SO 4 , NH 4 Cl, casein, and soybean was replaced at 180 ° C at 30 ° C. After incubation for 15 hours with shaking, cell growth and enzyme activity were measured. The results are shown in Table 3.

본 발명의 바실러스 속 WRD-2의 질소원에 따른 균체 생육 및 단백질분해효소의 활성Cell Growth and Protease Activity According to Nitrogen Sources of WRD-2 of the Genus Bacillus 질소원Nitrogen source 균체생육 (660nm에서의 흡광도)Cell growth (absorbance at 660 nm) 단백질분해 효소 활성 (U/㎖)Protease Activity (U / mL) 대두Big head 2.52932.5293 82.1682.16 맥아추출물Malt Extract 2.04732.0473 45.4345.43 펩톤peptone 1.97541.9754 45.2545.25 효모추출물Yeast extract 2.61832.6183 91.8891.88 카세인casein 2.37132.3713 80.2080.20 (NH4)2SO4 (NH 4 ) 2 SO 4 0.73170.7317 20.8820.88 NH4ClNH 4 Cl 1.08401.0840 11.0211.02

균체 생육과 단백질분해효소의 활성은 복합질소원을 사용하였을때 대체로 양호하였다. 특히, 균체 생육은 효모추출물을 첨가한 배지에서 가장 높았으며, 효소 활성도 효모추출물을 첨가한 배지에서 91.88U/㎖으로 가장 높았다. 암모니아 형태의 질소원이 사용된 경우 효소 활성이 상대적으로 저조하였는데, 이는 Himelbloom 등에 의해 보고된 바와 동일하였다(Himelbloom, B. H. and H. M. Hassen. 1986. Effect of cysteine on growth, protease production, and catalase activity of Pseudomonase fluorescens. Appl. Environ. Microbiol. 51 : 418 - 421).Cell growth and protease activity were generally good when using complex nitrogen sources. In particular, cell growth was highest in the medium containing yeast extract, and the enzyme activity was the highest as 91.88 U / mL in the medium containing yeast extract. The enzyme activity was relatively low when the nitrogen source in the ammonia form was used, which is the same as reported by Himelbloom et al. (Himelbloom, BH and HM Hassen. 1986. Effect of cysteine on growth, protease production, and catalase activity of Pseudomonase fluorescens) Appl.Environ.Microbiol . 51: 418-421).

단백질분해효소의 활성이 질소원으로서 효모추출물을 사용하였을 때 가장 높은 점을 감안하여 효모추출물의 농도를 0%, 1%, 2%, 3%, 4%, 5%로 하여 30℃에서 15시간 배양 후 단백질분해효소의 활성을 측정하였다. 그 결과 효모추출물의 농도가 4%일때 다른 농도에 비해 상대적으로 단백질분해효소의 활성이 가장 높았다. 그 결과를 도 5에 나타내었다.
Considering that yeast extract was the highest when protease activity was used as a nitrogen source, the concentration of yeast extract was 0%, 1%, 2%, 3%, 4%, 5%, and cultured for 15 hours at 30 ° C. The activity of the protease was then measured. As a result, when the concentration of yeast extract was 4%, the activity of protease was the highest compared to other concentrations. The results are shown in FIG.

실시예 6: 조효소액의 제조 및 pH와 온도에 따른 조효소액의 효소 활성Example 6 Preparation of Coenzyme Solution and Enzyme Activity of Coenzyme Solution According to pH and Temperature

pH 및 온도에 따른 WRD-2 유래 단백질분해효소의 활성을 측정하기 위하여 LB 액체배지 200ml에 전배양액 3%를 접종하고 180rpm으로 30℃에서 15시간 배양하였다. 이 배양액으로부터 조효소액을 제조하기 위하여 배양액을 10,000×g으로 20분간 원심분리한 후 상등액을 취하여 조효소액으로 하였다. pH에 따른 조효소액의 효소 활성을 알아보기 위하여, pH를 4.0 내지 7.0으로 조정하기 위해서는 0.02M 시트르산-인산나트륨 이염기성 버퍼(citric acid-sodium phosphate dibasic buffer)를, pH 7.0 내지 8.0으로 조정하기 위해서는 0.02M 인산나트륨-일염기성 인산나트륨 이염기성 버퍼(sodium phosphate mono basic sodium phosphate dibasic buffer)를, pH 8.0 내지 9.0으로 조정하기 위해서는 0.02M Tris-HCl 버퍼를, pH 9.0 내지 11.0으로 조정하기 위해서는 0.02M 글리신-NaOH(glycine-NaOH) 버퍼를 사용하였다. 각각 pH 농도별로 0.6% 카세인(w/v) 기질용액에 0.5㎖를 혼합하여 37℃에서 1시간 동안 반응시킨 후 효소 활성을 측정하였다. 온도 변화에 따른 조효소액의 효소 활성을 측정하기 위하여 pH를 WRD-2 조효소액의 최적 효소활성을 갖는 pH 9.0으로 조정하고, 이 조효소액과 0.6% 카세인(w/v) 기질용액과 혼합한 후 20℃, 30℃, 40℃, 50℃, 60℃ 및 70℃에서 반응시켜 효소 활성을 측정하였다. 그 결과를 도 6 및 도 7에 나타내었다.In order to measure the activity of WRD-2-derived protease according to pH and temperature, 3% of the preculture was inoculated into 200 ml of LB liquid medium and incubated at 180 ° C. for 15 hours at 30 ° C. To prepare a crude enzyme solution from this culture solution, the culture solution was centrifuged at 10,000 x g for 20 minutes, and then the supernatant was taken as a crude enzyme solution. In order to determine the enzyme activity of the crude enzyme solution according to pH, 0.02M citric acid-sodium phosphate dibasic buffer to adjust the pH to 4.0 to 7.0, to adjust the pH to 7.0 to 8.0 0.02M sodium phosphate monobasic sodium phosphate dibasic buffer 0.02M Tris-HCl buffer to adjust pH 8.0 to 9.0, 0.02M to adjust pH 9.0 to 11.0 Glycine-NaOH buffer was used. 0.5 ml of the casein (w / v) substrate solution for each pH concentration was mixed and reacted at 37 ° C. for 1 hour, and then enzyme activity was measured. In order to measure the enzyme activity of the crude enzyme solution according to the temperature change, the pH was adjusted to pH 9.0 having the optimum enzyme activity of the WRD-2 crude enzyme solution, and then mixed with the crude enzyme solution and 0.6% casein (w / v) substrate solution. Enzyme activity was measured by reaction at 20 ° C, 30 ° C, 40 ° C, 50 ° C, 60 ° C and 70 ° C. The results are shown in FIGS. 6 and 7.

pH 6 내지 9의 비교적 넓은 pH 범위에서 단백질분해효소의 활성이 70% 이상을 나타내었으며, 반응 최적 pH는 6이었다. 따라서, 조효소액의 단백질분해효소는 중성임을 알 수 있었다. 한편, 조효소액은 20∼60℃에서 80% 이상의 높은 효소활성을 나타내었으며, 최적 반응온도는 40℃이었다.
In the relatively wide pH range of pH 6-9, the activity of the protease was 70% or more, and the reaction optimum pH was 6. Therefore, it was found that the protease of the crude enzyme solution was neutral. On the other hand, the crude enzyme solution showed a high enzyme activity of 80% or more at 20 ~ 60 ℃, the optimum reaction temperature was 40 ℃.

실시예 7: 혈전용해능 확인Example 7: Confirmation of thrombolytic ability

본 발명의 균주인 WRD-2의 혈전용해능을 확인하기 위하여 배양액을 원심 분리하여 Tris 버퍼(pH 7.2, 20mM)로 7:3의 비로 희석하였다. 이 효소 희석액 50㎕와 100㎕를 미리 준비한 피브린 플레이트(fibrin plate)에 떨어뜨린 후 37℃의 항온기에서 4시간 동안 반응시키고, 분해환의 지름으로부터 분해면적을 측정하였다. 피브린 플레이트 위에 효소액을 떨어뜨릴 때 지름 8mm의 여지원판(paper disk)을 이용하여 그 위에 효소액을 떨어뜨렸다.In order to confirm the thrombolytic ability of the strain of the present invention, WRD-2, the culture solution was centrifuged and diluted in a ratio of 7: 3 with Tris buffer (pH 7.2, 20 mM). 50 µl and 100 µl of this enzyme dilution were dropped onto a fibrin plate prepared in advance, and reacted for 4 hours at 37 ° C. in an incubator, and the degradation area was measured from the diameter of the degradation ring. When the enzyme solution was dropped on the fibrin plate, the enzyme solution was dropped on a 8 mm diameter paper disk.

피브린 플레이트는 피브리노겐(fibrinogen)에 트롬빈(thrombin)을 투여하여 제조하였다. 즉, 피브리노겐 0.06g을 0.1M 붕산염 버퍼(pH7.5) 10ml에 넣어 37℃로 맞춘 항온기에서 2시간 동안 방치하여 완전히 녹였다. 녹은 피브리노겐을 페트리접시(petri dish)에 10ml씩 분주하고 피브리노겐 10㎖당 트롬빈(5,000unit, 미국 SIGMA사 제품) 40unit을 페트리접시 전면에 골고루 퍼질 수 있도록 상하좌우로 적당하게 흔들면서 투여하였다(Astrup, T., Mullertz, S., The fibrin plate method for estimating fibrinolytic activity. Arch Biochem. Biophys., 40, 346(1952)). 그 결과를 도 8에 나타내었다.Fibrin plates were prepared by administering thrombin to fibrinogen. That is, 0.06 g of fibrinogen was added to 10 ml of 0.1 M borate buffer (pH7.5), and the mixture was left to stand at 37 ° C. for 2 hours to completely dissolve. Dissolved fibrinogen was dispensed in a petri dish by 10ml, and 40ml of thrombin (5,000units, manufactured by SIGMA, USA) per 10ml of fibrinogen was gently shaken up, down, left and right so as to spread evenly over the petri dish (Astrup, T., Mullertz, S., The fibrin plate method for estimating fibrinolytic activity.Arch Biochem. Biophys., 40 , 346 (1952)). The results are shown in FIG.

피브린 플레이트를 이용한 WRD-2의 혈전용해능은 2시간 간격으로 형성되는 분해환의 면적이 8시간까지 비례적으로 증가하는 경향을 나타내었는데, 이는 이 등(Lee Si Kyung 등, 1998, Medium Optimization for Fibrinolytic Enzyme Production by Bacillus subtilis KCK-7 Isolated from Korean Traditional Chungkookjang. Kor. J. Appl. Microbiol. Biotechnol. 26 : 226 - 231)과 길 등(Kil Ji Oeun 등, 1998, Production and Characterization of Fibrinoloytic enzyme : Optimal Codition for Production of the Enzyme from Bacillus sp. KP-6408 Isolated from Chungkook-jang. J. Korean Soc. Food Sci. Nutr. 27 : 51 - 56)에 의해 보고된 결과와 동일하였다.
The thrombolytic ability of WRD-2 using fibrin plates tended to increase proportionally to the area of the dissociated rings formed at two-hour intervals up to eight hours, such as Lee Si Kyung et al., 1998, Medium Optimization for Fibrinolytic. .... enzyme Production by Bacillus subtilis KCK-7 Isolated from Korean Traditional Chungkookjang Kor J. Appl Microbiol Biotechnol 26:. 226 - 231) and roads, etc. (Kil Ji Oeun, etc., 1998, Production and Characterization of Fibrinoloytic enzyme: Optimal Codition for Production of the Enzyme from Bacillus sp.KP -6408 Isolated from Chungkook-jang.J . Korean Soc.Food Sci.Nutr . 27 : 51-56 ).

이상, 상기 실시예를 통하여 설명한 바와 같이 토양에서 분리한 본 발명의 바실러스 속 WRD-2는 비교적 저온인 20∼40℃에서 90% 이상의 높은 효소 활성을 갖는 단백질분해효소를 생산함으로써 혈전용해능이 매우 우수하므로, 상기 WRD-2 및 이 균주가 생산하는 세포외 단백질분해효소를 유효성분으로 하는 혈전용해제 조성물은 의약 산업상 매우 유용한 발명인 것이다.As described above, the Bacillus genus WRD-2 of the present invention isolated from the soil as described through the above example has very high thrombolytic ability by producing protease having a high enzyme activity of 90% or more at 20-40 ° C. at a relatively low temperature. Therefore, the thrombolytic composition comprising the WRD-2 and the extracellular protease produced by the strain as an active ingredient is a very useful invention in the pharmaceutical industry.

Claims (2)

세포외 단백질분해효소를 생산하는 토양에서 분리한 신규한 바실러스 속 WRD-2(Bacillus sp. WRD-2, KCTC 0869BP).Novel Bacillus sp. WRD-2 ( Bacillus sp. WRD-2, KCTC 0869BP) isolated from soil producing extracellular protease. 토양에서 분리한 바실러스 속 WRD-2(Bacillus sp. WRD-2, KCTC 0869BP) 균주 배양액을 원심분리하여 얻은 상등액을 유효성분으로 함유함을 특징으로 하는 혈전용해제 조성물.A thrombolytic composition comprising a supernatant obtained by centrifuging Bacillus sp. WRD-2 (KCTC 0869BP) strain culture medium isolated from soil as an active ingredient.
KR1020010011804A 2001-03-07 2001-03-07 Novel Bacillus sp. WRD-2 isolated from soil and fibrinolytic agent composition comprising extracellular protease produced by the WRD-2 isolated from soil as an effective component KR100737736B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010011804A KR100737736B1 (en) 2001-03-07 2001-03-07 Novel Bacillus sp. WRD-2 isolated from soil and fibrinolytic agent composition comprising extracellular protease produced by the WRD-2 isolated from soil as an effective component

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010011804A KR100737736B1 (en) 2001-03-07 2001-03-07 Novel Bacillus sp. WRD-2 isolated from soil and fibrinolytic agent composition comprising extracellular protease produced by the WRD-2 isolated from soil as an effective component

Publications (2)

Publication Number Publication Date
KR20020071646A KR20020071646A (en) 2002-09-13
KR100737736B1 true KR100737736B1 (en) 2007-07-10

Family

ID=27696706

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010011804A KR100737736B1 (en) 2001-03-07 2001-03-07 Novel Bacillus sp. WRD-2 isolated from soil and fibrinolytic agent composition comprising extracellular protease produced by the WRD-2 isolated from soil as an effective component

Country Status (1)

Country Link
KR (1) KR100737736B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100737735B1 (en) * 2001-03-07 2007-07-10 (주)네오바이오텍 Novel Bacillus sp. WRD-2 isolated from soil and antifungal agent composition thereof
KR20030090243A (en) * 2002-05-21 2003-11-28 주식회사풀무원 Bacillus subtilis DM185(KCCM-10372) which produces fibrinolytic enzymes
KR101101369B1 (en) * 2010-03-11 2012-01-02 조선대학교산학협력단 Acetobacter sp. strain having fibrinolytic activity isolated from fermentation broth of pine needles and uses thereof

Also Published As

Publication number Publication date
KR20020071646A (en) 2002-09-13

Similar Documents

Publication Publication Date Title
Desjardins et al. Growth of bifidobacteria and their enzyme profiles
Hoshino et al. Isolation of a Pseudomonas species from fish intestine that produces a protease active at low temperature
EP0495401B1 (en) Novel alkaline proteinase and process for producing the same
Prowe et al. Anaerobranca gottschalkii sp. nov., a novel thermoalkaliphilic bacterium that grows anaerobically at high pH and temperature.
Chandrasekaran et al. Exploring the in vitro thrombolytic activity of nattokinase from a new strain Pseudomonas aeruginosa CMSS
Tekin et al. Alkaline protease production of Bacillus cohnii APT5
Okamura-Matsui et al. Characteristics of a cheese-like food produced by fermentation of the mushroom Schizophyllum commune
Hawumba et al. Thermophilic protease-producing Geobacillus from Buranga hot springs in Western Uganda
KR100737736B1 (en) Novel Bacillus sp. WRD-2 isolated from soil and fibrinolytic agent composition comprising extracellular protease produced by the WRD-2 isolated from soil as an effective component
KR100588521B1 (en) Bacillus subtilis CHKJ1339 with Higher Ability of Blood Clot Dissolution and Activating Immune Cells
Abdelghani et al. Isolation and mutagenesis of streptokinase producing bacteria
KR101156161B1 (en) Bacillus subtilis hj18-4 oligotrophic strain isolated from memil soksungjang and method for making fermentation food by using same
Smitha et al. Application of Box-Behnken design for the optimization of culture conditions for novel fibrinolytic enzyme production by Bacillus altitudinis S-CSR 0020
Raj et al. Biosynthesis and characterization of a novel fibrinolytic alkaline serine protease from newly isolated Bacillus flexus BF12 for biomedical applications
Mukhtar Biosynthesis of protease from Lactobacillus paracasei: kinetic analysis of fermentation parameters
KR20130033026A (en) Novel bacillus amyloliquefaciens by04 having high protease producing activity and process for producing protease using the same
KR100465852B1 (en) Bacillus sp. I-52 which produces highly active alkaline protease
Malik et al. Effect of some nutritional and environmental factors on extracellular protease production by Pseudomonas sp. B-25
KR100466264B1 (en) Bacillus producing oxidant and detergent-resistant protease
CA1086670A (en) .beta.-GALACTOSIDASE
Chaudhuri et al. Proteolytic Activity of Bacillus amyloliquefaciens UEF01 Endophytic to Carnivorous Plant Utricularia exoleta R. Br.
Kurniatanty et al. Enzymatic Activity of Protease Producing Bacteria from Tofu Waste
KR0127099B1 (en) Novel bacillus sp. and producing method of protease
Gond et al. Agro Waste Mediated Production of Fibrinolytic Enzyme and Its Optimization and Application
KR100478214B1 (en) Fibrinolytic enzyme derived from Bacillus sp. HLN-21 strain and, isolation and purification method thereof

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
J204 Request for invalidation trial [patent]
J301 Trial decision

Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20100512

Effective date: 20110419

Free format text: TRIAL NUMBER: 2010100001236; TRIAL DECISION FOR INVALIDATION REQUESTED 20100512

Effective date: 20110419

J2X1 Appeal (before the patent court)

Free format text: INVALIDATION

Free format text: TRIAL NUMBER: 2011200004615; INVALIDATION

J302 Written judgement (patent court)

Free format text: JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20110512

Effective date: 20111216

Free format text: TRIAL NUMBER: 2011200004615; JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20110512

Effective date: 20111216

J2X2 Appeal (before the supreme court)

Free format text: APPEAL BEFORE THE SUPREME COURT FOR INVALIDATION

Free format text: TRIAL NUMBER: 2012300000139; APPEAL BEFORE THE SUPREME COURT FOR INVALIDATION

J303 Written judgement (supreme court)

Free format text: JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20120110

Effective date: 20120614

Free format text: TRIAL NUMBER: 2012300000139; JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20120110

Effective date: 20120614

FPAY Annual fee payment

Payment date: 20130704

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20140702

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20150703

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20170104

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20170824

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20181023

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20190704

Year of fee payment: 13